Literature DB >> 11410934

The active site of HIV-1 protease.

P P Mager1.   

Abstract

The active site of the homodimeric HIV-1 protease includes six amino acids (triads AspThrGly found in each monomer) in amino acid positions 25 to 27 and 25' to 27'. Up to now, the role of Thr26 and Thr26', and Gly27 and Gly27', is unknown. It is hypothesized that strong hydrogen-bonding forces between the Thr26 and Thr26' residues stabilize the conformational state of the active site, and that the function of Gly27 and Gly27' is to accommodate and bind a substrate in a position in which the catalytic Asp25 and Asp25' carboxylate groups can attack the amide moiety of a substrate. Copyright 2001 John Wiley & Sons, Inc. Med Res Rev, 21, No. 4, 348-353, 2001

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410934     DOI: 10.1002/med.1012

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  10 in total

1.  An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.

Authors:  Zainab K Sanusi; Thavendran Govender; Glenn E M Maguire; Sibusiso B Maseko; Johnson Lin; Hendrik G Kruger; Bahareh Honarparvar
Journal:  J Comput Aided Mol Des       Date:  2018-02-03       Impact factor: 3.686

2.  3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists.

Authors:  Yogesh D Aher; Avantika Agrawal; Prasad V Bharatam; Prabha Garg
Journal:  J Mol Model       Date:  2007-02-16       Impact factor: 1.810

3.  Dynamical basis for drug resistance of HIV-1 protease.

Authors:  Yi Mao
Journal:  BMC Struct Biol       Date:  2011-07-08

4.  Whiskers-less HIV-protease: a possible way for HIV-1 deactivation.

Authors:  Mohammad Reza Dayer; Mohammad Saaid Dayer
Journal:  J Biomed Sci       Date:  2013-09-12       Impact factor: 8.410

5.  Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach.

Authors:  Mohammad Reza Dayer; Mohammad Saaid Dayer
Journal:  Mol Biol Res Commun       Date:  2014-12

6.  Interdependence of Inhibitor Recognition in HIV-1 Protease.

Authors:  Janet L Paulsen; Florian Leidner; Debra A Ragland; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2017-04-11       Impact factor: 6.006

7.  Conformational Variation in Enzyme Catalysis: A Structural Study on Catalytic Residues.

Authors:  Ioannis G Riziotis; António J M Ribeiro; Neera Borkakoti; Janet M Thornton
Journal:  J Mol Biol       Date:  2022-02-28       Impact factor: 5.469

8.  The structural, dynamic, and thermodynamic basis of darunavir resistance of a heavily mutated HIV-1 protease using molecular dynamics simulation.

Authors:  Yaser Shabanpour; Sharareh Sajjadi; Esmaeil Behmard; Parviz Abdolmaleki; Amir Homayoun Keihan
Journal:  Front Mol Biosci       Date:  2022-08-15

9.  Off-Target-Based Design of Selective HIV-1 PROTEASE Inhibitors.

Authors:  Gabriele La Monica; Antonino Lauria; Alessia Bono; Annamaria Martorana
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

10.  A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells.

Authors:  Satoru Aoyama; Shunichiro Yasuda; Huixin Li; Daisuke Watanabe; Yoshihiro Umezawa; Keigo Okada; Ayako Nogami; Osamu Miura; Norihiko Kawamata
Journal:  Int J Mol Med       Date:  2022-02-04       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.